MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression

Cell Death and Disease

Volumn 5, Issue 9, 2014, Pages

  Zha, Y ^a   Xia, Y ^a,b   Ding, J ^b   Choi, J H ^b,c   Yang, L ^d   Dong, Z ^b   Yan, C ^b   Huang, S ^b   Ding, H F ^b  

^a Three Gorges University College of Medicine   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c AUGUSTA UNIVERSITY   (United States)

^d SOUTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENICITY; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; M PHASE CELL CYCLE CHECKPOINT; MITOSIS; MUVB BMYB FOXM1 COMPLEX; NEUROBLASTOMA; NEUROBLASTOMA CELL LINE; ONCOGENE; ONCOGENE MEIS 2; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UPREGULATION; CELL DIVISION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

CELL CYCLE PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MEIS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HUMANS; NEUROBLASTOMA; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84927771579     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.370     Document Type: Article

References (50)

1. Berkes CA, Bergstrom DA, Penn BH, Seaver KJ, Knoepfler PS, Tapscott SJ. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol Cell 2004; 14: 465-477.
2. Bessa J, Tavares MJ, Santos J, Kikuta H, Laplante M, Becker TS et al. meis1 regulates cyclin D1 and c-myc expression, and controls the proliferation of the multipotent cells in the early developing zebrafish eye. Development 2008; 135: 799-803.
3. Capdevila J, Tsukui T, Esteban CR, Zappavigna V, Belmonte JCI. Control of vertebrate limb outgrowth by the proximal factor MEIS2 and distal antagonism of BMPs by gremlin. Mol Cell 1999; 4: 839-849.
4. Dibner C, Elias S, Frank D. XMeis3 protein activity is required for proper hindbrain patterning in Xenopus laevis embryos. Development 2001; 128: 3415-3426.
5. Heine P, Dohle E, Bumsted-O'Brien K, Engelkamp D, Schulte D. Evidence for an evolutionary conserved role of homothorax/Meis1/2 during vertebrate retina development. Development 2008; 135: 805-811.
6. Mercader N, Leonardo E, Azpiazu N, Serrano A, Morata G, Martinez-A C et al. Conserved regulation of proximodistal limb axis development by Meis1/Hth. Nature 1999; 402: 425-429.
7. Vlachakis N, Choe SK, Sagerstrom CG. Meis3 synergizes with Pbx4 and Hoxb1b in promoting hindbrain fates in the zebrafish. Development 2001; 128: 1299-1312.
8. Zhang X, Friedman A, Heaney S, Purcell P, Maas RL. Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. Genes Dev 2002; 16: 2097-2107.
9. Hyman-Walsh C, Bjerke GA, Wotton D. An autoinhibitory effect of the homothorax domain of Meis2. FEBS J 2010; 277: 2584-2597.
10. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci 2001; 98: 1176-1181.
11. Israeli O, Goldring-Aviram A, Rienstein S, Ben-Baruch G, Korach J, Goldman B et al. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet 2005; 160: 35-42.
12. Halder SK, Cho YJ, Datta A, Anumanthan G, Ham AJ, Carbone DP et al. Elucidating the mechanism of regulation of transforming growth factor beta Type II receptor expression in human lung cancer cell lines. Neoplasia 2011; 13: 912-922.
13. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714-3725.
14. Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG, Hirokawa K et al. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 2001; 29: 856-863.
15. Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: Potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci 2001; 98: 13120-13125.
16. Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik BDC, van Kampen AHC et al. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 2001; 71: 214-221.
17. Geerts D, Schilderink N, Jorritsma G, Versteeg R. The role of the MEIS homeobox genes in neuroblastoma. Cancer Lett 2003; 197: 87-92.
18. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-216.
19. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362: 2202-2211.
20. Koo CY, Muir KW, Lam EW. FOXM1: from cancer initiation to progression and treatment. Biochim Biophys Acta 2012; 1819: 28-37.
21. Sadasivam S, DeCaprio JA. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer 2013; 13: 585-595.
22. Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10: 221-237.
23. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26: 1324-1337.
24. Hans F, Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001; 20: 3021-3027.
25. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008; 15: 1153-1162.
26. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12: 385-392.
27. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4: 253-265.
28. Piperno G, LeDizet M, Chang XJ. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 1987; 104: 289-302.
29. Nigg EA, Stearns T. The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol 2011; 13: 1154-1160.
30. Luders J, Stearns T. Microtubule-organizing centres: a re-evaluation. Nat Rev Mol Cell Biol 2007; 8: 161-167.
31. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825-2837.
32. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
33. Down CF, Millour J, Lam EW, Watson RJ. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochim Biophys Acta 2012; 1819: 855-862.
34. Sadasivam S, Duan S, DeCaprio JA. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 2012; 26: 474-489.
35. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7: 126-136.
36. Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 2005; 65: 5181-5189.
37. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005; 25: 10875-10894.
38. Wang Z, Park HJ, Carr JR, Chen YJ, Zheng Y, Li J et al. FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors. Cancer Res 2011; 71: 4292-4302.
39. Yang Y, Hwang CK, D'Souza UM, Lee S-H, Junn E, Mouradian MM. Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription. J Biol Chem 2000; 275: 20734-20741.
40. Bhat UG, Zipfel PA, Tyler DS, Gartel AL. Novel anticancer compounds induce apoptosis in melanoma cells. Cell Cycle (Georgetown, Tex) 2008; 7: 1851-1855.
41. Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther 2008; 7: 2022-2032.
42. Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat Chem 2011; 3: 725-731.
43. Budirahardja Y, Gönczy P. Coupling the cell cycle to development. Development 2009; 136: 2861-2872.
44. Cui H, Li T, Ding HF. Linking of N-Myc to death receptor machinery in neuroblastoma cells. J Biol Chem 2005; 280: 9474-9481.
45. Cui H, Schroering A, Ding HF. p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 2002; 1: 679-686.
46. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008; 4: 44-57.
47. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
48. Wang X, Choi JH, Ding J, Yang L, Ngoka LC, Lee EJ et al. HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation. BMC Genomics 2013; 14: 830.
49. Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24: 5070-5078.
50. Chen QR, Song YK, Wei JS, Bilke S, Asgharzadeh S, Seeger RC et al. An integrated cross-platform prognosis study on neuroblastoma patients. Genomics 2008; 92: 195-203.